Investigates biochemical and proteomic mechanisms of Alzheimer's disease and develops molecular biomarkers for diagnosis and monitoring. Uses mass spectrometry, protein chemistry, transgenic models, and postmortem human brain data to construct molecular networks associated with pathology and clinical progression.